Header Logo

Connection

Kathleen Moore to Retreatment

Back to Details
This is a "connection" page, showing publications Kathleen Moore has written about Retreatment.
Kathleen Moore
Connection Strength
0.038
Retreatment
  1. Evaluation of Prexasertib, a Checkpoint Kinase 1 Inhibitor, in a Phase Ib Study of Patients with Squamous Cell Carcinoma. Clin Cancer Res. 2018 07 15; 24(14):3263-3272.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.